glp-1 bad breath drugs may be a of fresh air for gum GLP-1 and Shortness of Breath:

Hamilton RA, Briceland LL, Andritz MH

Here, the combination with other drugs such as RAAS blockers, SGLT2 inhibitors, and mineralocorticoid receptor agonists, which have also displayed renoprotective effects, needs to be taken into account as well

Ketoacidosis is a serious condition and may need to be treated in the hospital

Although DSM-5 diagnosis is defined through multiple behavioral criteria encompassing impaired control, social dysfunction, continued use despite harm, and tolerance or withdrawal, converging clinical and preclinical evidence indicates that the core pathological feature of SUDs is the progressive loss of control over intake (O'Brien, 2005)

A1C suggests one story, continuous glucose monitoring points to another, and patient symptoms may not match either